Amjad Alwaal, MD
Urology · Huntington, WVNPI 1194153825
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,588 of the $4,630 with a category attached, or 77.5%. Boston Scientific accounts for 60.6% of it on its own, with 8 other manufacturers making up the rest.
Across 48 payments — averaging $96.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Neotract Inc.$646
- Coloplast$433
- Kerecis Limited$348
- Innovation Technologies Inc$258
- Endo Pharmaceuticals Inc.$59
- plus $81 from 3 others
What the payments were for
- Travel & lodging$1,04222%
- Food & beverage$3,58878%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 28 | $2,804 |
| Neotract Inc. | 6 | $646 |
| Coloplast | 3 | $433 |
| Kerecis Limited | 2 | $348 |
| Innovation Technologies Inc | 2 | $258 |
| Endo Pharmaceuticals Inc. | 4 | $59 |
| Antares Pharma, Inc. | 1 | $50 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$1,392
- Moses 550 D\F\L$908
- UroLift$606
- GENERAL ERECTILE DYSFUNCTION$513
- Kerecis GraftGuide$348
- TITAN$289
- Irrisept$258
- AMS 700 CXR RTE KIT$258
- AMS 700$248
How this compares
$4,630 in reported general payments places this provider in the 70th percentile of 67 urology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $11,094 |
| Tamsulosin Hcl | 116 | $1,201 |
| Trospium Chloride | 11 | $704 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 13 | $351 |
| Oxybutynin Chloride ErOxybutynin Chloride | 40 | $248 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 40 | $204 |
| Finasteride | 29 | $187 |
| Sildenafil Citrate | 18 | $103 |
| Ciprofloxacin Hcl | 13 | $82 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $51 |
Paid to pharmacies, not to this prescriber.
Other urology in Huntington
- Stanley ZaslauHuntington$14K
- Rocco MorabitoHuntington$6K
- Margaret VerebHuntington$4K
- James JensenHuntington$4K
- Frederick MartinezHuntington$3K
- Justyn BlankenshipHuntington$3K
- Roger RobertsonHuntington$3K
- Rocco MorabitoHuntington$3K
- Lawrence WynerHuntington$2K
- Mark ThomasHuntington$787
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.